Literature DB >> 17711395

Time course of intracranial hypertension after traumatic brain injury.

Nino Stocchetti1, Angelo Colombo, Fabrizio Ortolano, Walter Videtta, Roberta Marchesi, Luca Longhi, Elisa R Zanier.   

Abstract

High intracranial pressure (HICP) may be a very early event after traumatic brain injury (TBI), but in most cases, especially when contusions and edema develop over time, HICP will worsen over succeeding days. This study describes the incidence and severity of elevated intracranial pressure (ICP) after TBI and attempts to document its time course. In this prospective study, 201 TBI patients in whom ICP was monitored for more than 12 h were evaluated. ICP was measured, digitalized, and analyzed after manual filtering. The number of episodes of HICP and the mean ICP value for every 12-h interval were calculated. When monitoring was concluded, the highest mean ICP collected in every patient was identified. A total of 21,000 h of ICP monitoring were recorded. Active treatment to prevent or reduce HICP was used in 200 patients. HICP was documented in 155 cases. Half of the patients had their highest mean ICP during the first 3 days after injury, but many showed delayed ICP elevation, with 25% showing highest mean ICP after day 5. In these cases, HICP was significantly worse and required more intense therapies.

Entities:  

Mesh:

Year:  2007        PMID: 17711395     DOI: 10.1089/neu.2007.0300

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  41 in total

1.  Patterns of increased intracranial pressure after severe traumatic brain injury.

Authors:  Kristine H O'Phelan; Dalnam Park; Jimmy T Efird; Katherine Johnson; Melanie Albano; Juliet Beniga; Deborah M Green; Cherylee W J Chang
Journal:  Neurocrit Care       Date:  2009-01-23       Impact factor: 3.210

2.  Salutary Effects of Estrogen Sulfate for Traumatic Brain Injury.

Authors:  Hyunki Kim; Betul Cam-Etoz; Guihua Zhai; William J Hubbard; Kurt R Zinn; Irshad H Chaudry
Journal:  J Neurotrauma       Date:  2015-04-22       Impact factor: 5.269

Review 3.  Management of intracranial pressure.

Authors:  Thomas J Wolfe; Michel T Torbey
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 4.  Intracranial pressure monitoring for traumatic brain injury in the modern era.

Authors:  Llewellyn C Padayachy; Anthony A Figaji; M R Bullock
Journal:  Childs Nerv Syst       Date:  2010-04       Impact factor: 1.475

5.  Intracranial pressure thresholds in severe traumatic brain injury: we are not sure : Prudent clinical practice despite dogma or nihilism.

Authors:  Nino Stocchetti; Daniele Poole; David O Okonkwo
Journal:  Intensive Care Med       Date:  2018-07-05       Impact factor: 17.440

6.  Timing of intracranial hypertension following severe traumatic brain injury.

Authors:  Deborah M Stein; Megan Brenner; Peter F Hu; Shiming Yang; Erin C Hall; Lynn G Stansbury; Jay Menaker; Thomas M Scalea
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

Review 7.  The use of targeted temperature management for elevated intracranial pressure.

Authors:  Jesse J Corry
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

8.  Progenitor cells: therapeutic targets after traumatic brain injury.

Authors:  Robert A Hetz; Supinder S Bedi; Scott Olson; Alex Olsen; Charles S Cox
Journal:  Transl Stroke Res       Date:  2012-05-22       Impact factor: 6.829

9.  The course of intracranial pressure in traumatic brain injury: relation with outcome and CT-characteristics.

Authors:  Rosette Bremmer; Bauke M de Jong; Michiel Wagemakers; Joost G Regtien; Joukje van der Naalt
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

10.  Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury.

Authors:  Georgene W Hergenroeder; Anthony N Moore; J Philip McCoy; Leigh Samsel; Norman H Ward; Guy L Clifton; Pramod K Dash
Journal:  J Neuroinflammation       Date:  2010-03-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.